| 0000-00-00 |
|
|
|
External link to document |
| 2023-02-10 |
1 |
Complaint |
expiration of U.S. Patent No.
7,449,464 (“the ’464”); U.S. Patent No. 8,475,842 (“the ’842 patent”); and U.S.…U.S. Patent No.
8,859,562 (“the ’562 patent”). These patents are referred to collectively herein as the… the ’842 patent, including at
least claims 1 and 7 of the ’842 patent, and the ’842 patent has been … 1. This is an action for patent infringement under the patent laws of the United States,
35 U.S.C…United States Patent and Trademark Office (the
“USPTO”) duly and lawfully issued the ’464 patent, entitled |
External link to document |
| 2024-07-17 |
103 |
Exhibit B |
date of U.S. Patent Nos. 7,449,464
(“the ’464 patent”) and 8,859,562 (“the ’562 patent”), except as…of any patent that is subject to a
PARP Patent Agreement and the rights afforded to any patent that is…of any patent subject to a PARP Patent Agreement, regardless
whether they concern the patents or products…any patent that is subject to a PARP Patent Agreement,”
and “the rights afforded to any patent that…agreement concerning any patent or patent application to which the ’562
patent claims priority or which |
External link to document |
| 2024-08-27 |
113 |
Order |
11,970,530 ("the '530 patent"), 8,475,842 ("the '842 patent"), and 11,633,396 (… ("the '396 patent")
in connection with Cipla's submission of ANDA No. 219410: Counts…this action
related to the infringement of U.S. Patent Nos. 7,859,562, 11,975,001, and 12,048,695 are …10 February 2023
3:23-cv-00796
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2024-09-25 |
127 |
Order |
in or to U.S.
Patent Nos. 8,859,562 (the “562 patent”), 8,071,579 (the “579 patent”), and 8,143,241…the “241
patent”). Defendants argue that the information sought regarding the 562 patent is relevant…562, 589, and 241 patents are relevant
to their obviousness-type double patenting defense. The Court… to the 562 patent because said information
concerns whether claim 1 of the 562 patent covers only …obtaining licenses for the 562
patent because of the likelihood that the patent is invalid because it is obvious |
External link to document |
| 2023-11-13 |
51 |
Stipulation and Order |
(nO, asserting that U.S.
Patent Nos. 7,449,464 ("the '464 patent"), 8,475,842 ("the…the '464 patent,
the '842 patent, the '562 patent and the '396 patent (ECF No. 36)…infringement of the '464
patent, the '842 patent, and the '562 patent under 35 U.S.C. § 271 (…States Patent and
Trademark Office issued U.S. Patent No. 11,633,396 ("the '396 patent"…;the '842 patent") and 8,859,562 ("the '562
patent") are invalid or would not |
External link to document |
| 2024-04-05 |
65 |
Letter |
issues
relating to the validity of two patents, No. 7,449,464 and 8,859,562, that have been asserted …common in cases like this
one involving claims of patent infringement brought under the Hatch-Waxman Act…bar, not just on use of the information,
but on patent prosecution and competitive decision-making generally…10 February 2023
3:23-cv-00796
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
